Related Experiment Video
Updated: Feb 18, 2026

Array Comparative Genomic Hybridization Array CGH for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray
Robin Z Hayeems1,2, Jasmin Bhawra3, Kate Tsiplova4
1Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada. robin.hayeems@sickkids.ca.
Insights
Whole-genome sequencing (WGS) in children with developmental delay prompts more specialist visits than chromosome microarray (CMA), but fewer lab tests. Downstream care costs are generally low, guiding tailored treatments.
Area of Science:
- Genomics
- Pediatric Medicine
- Healthcare Economics
Background:
- Whole-genome sequencing (WGS) is increasingly used in pediatrics.
- Its impact on healthcare activities and costs compared to chromosome microarray (CMA) needs evaluation.
- Understanding downstream care is crucial for optimal genomic testing implementation.
Purpose of the Study:
- To compare healthcare activities and costs following pediatric WGS versus CMA in children with developmental delay.
- To analyze how WGS results (diagnostic vs. non-diagnostic) influence downstream care.
- To assess the economic implications of WGS in complex pediatric cases.
Main Methods:
- Prospective study of 101 children with developmental delay over one year.
- Ascertainment and costing of healthcare activities prompted by WGS and CMA.
- Comparative analysis of activities and costs between WGS and CMA, considering WGS result status.
Main Results:
- Ongoing care constituted the majority (88.6%) of post-test activities.
- CMA prompted more laboratory tests (0.55 vs. 0.09; p=0.007), while WGS prompted more specialist visits (0.41 vs. 0; p=0.016).
- WGS results significantly modified the number of activities (p<0.001); diagnostic WGS led to tailored care, while CMA prompted further investigations.
Conclusions:
- WGS in pediatric care shifts focus from broad investigations to targeted management based on genotypic findings.
- Downstream healthcare activity costs prompted by WGS are typically low for most patients.
- Effective integration of WGS requires careful evaluation of its downstream care and cost consequences.
Abstract:
The clinical use of whole-genome sequencing (WGS) is expected to alter pediatric medical management. The study aimed to describe the type and cost of healthcare activities following pediatric WGS compared to chromosome microarray (CMA). Healthcare activities prompted by WGS and CMA were ascertained for 101 children with developmental delay over 1 year. Activities following receipt of non-diagnostic CMA were compared to WGS diagnostic and non-diagnostic results. Activities were costed in 2016 Canadian dollars (CDN). Ongoing care accounted for 88.6% of post-test activities. The mean number of lab tests was greater following CMA than WGS (0.55 vs. 0.09; p = 0.007). The mean number of specialist visits was greater following WGS than CMA (0.41 vs. 0; p = 0.016). WGS results (diagnostic vs. non-diagnostic) modified the effect of test type on mean number of activities (p < 0.001). The cost of activities prompted by diagnostic WGS exceeded $557CDN for 10% of cases. In complex pediatric care, CMA prompted additional diagnostic investigations while WGS prompted tailored care guided by genotypic variants. Costs for prompted activities were low for the majority and constitute a small proportion of total test costs. Optimal use of WGS depends on robust evaluation of downstream care and cost consequences.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
DNA Microarrays
Genomics
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...